	Exploring risk factors and survival rates in invasive cervical carcinoma: New perspectives. Tunis Med Belhadj A, Boumeddane YK, Meddah D, Sahraoui T. PMID: 41832650 [PubMed - indexed for MEDLINE]
	CD27 expression is a clinically accessible biomarker for predicting immunotherapy response in melanoma. NPJ Precis Oncol Xia P, Yang H, Yu P, Miao Y, Tang L, Wang Y, Li B, Wang Z, Jiang G, Chen K, Li S, Yang M. PMID: 41832290 [PubMed - as supplied by publisher]
	Cutaneous Melanoma: Association of Histopathological Subtypes and Breslow Thickness with Occupation and Residence in An observational study of 2,486 patients. Actas Dermosifiliogr Angel-Baldo J, Stoicev O, Barceló C, Matas-Nadal C, Soria X, Gatius S, Murata P, Nagore E, Marti RM. PMID: 41831776 [PubMed - as supplied by publisher]
	Frailty and survival outcomes in veterans with invasive cutaneous melanoma: A Veterans Affairs Cancer Registry retrospective cohort study. J Am Acad Dermatol Huhmann LB, Hwang JC, Kim DY, Nannini K, Do NV, Gaziano JM, Wheless LE, Fillmore NR, Hartman RI. PMID: 41831612 [PubMed - as supplied by publisher]
	The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024. Br J Dermatol Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T. PMID: 41831481 [PubMed - as supplied by publisher]
	A 43-Year-Old Man With Isolated Cutaneous Lymphomatoid Granulomatosis Presenting as a Chronic Necrotizing Ulcer of the Upper Arm. Am J Case Rep Adetiloye AO, Asif A, Badero OJ, Zimri T, Brissett-Williams NC. PMID: 41831228 [PubMed - indexed for MEDLINE]
	Porphyromonas gingivalis-Associated Modulation of Î²-Catenin Signaling in Oral Squamous Cell Carcinoma: Molecular Perspectives from Periodontal Dysbiosis. Molecules Hashim NT, Babiker R, Mohammed R, Elsheikh M, Padmanabhan V, Islam MS, Gesm Elseed M, Chaitanya NCSK, Siriwardena BSMS, Rahman MM, Gismalla BG. PMID: 41828887 [PubMed - indexed for MEDLINE]
	Heterogeneity of Hormone Receptors and HER2 in Breast Cancer Cutaneous Metastases: An Institutional Experience. Int J Mol Sci Iozzo R, Belcastro E, Fanelli GN, Cinacchi P, Ferrari P, Nicolini A, Scatena C. PMID: 41828595 [PubMed - indexed for MEDLINE]
	Surgical Management of Stage IV Melanoma: Clinical, Molecular, and Therapeutic Considerations. Int J Mol Sci Uche IK, Lyons JM 3rd. PMID: 41828551 [PubMed - indexed for MEDLINE]
	Dermoscopy of Cutaneous Melanoma Metastases: A Comprehensive Literature Review. Diagnostics (Basel) D'Onghia M, Agueci S, Scotti B, Falcinelli F, Lo Conte S, Cartocci A, Cortez CD, Dika E, Tognetti L, Rubegni P, Perrot J, Cinotti E. PMID: 41828014 [PubMed]
	Aquaporins as Regulators of Cutaneous Malignancies: A Comprehensive Review. Cells Camillo L, Zavattaro E, Savoia P. PMID: 41827892 [PubMed - indexed for MEDLINE]
	Impact on Quality of Life and Psychological Dimensions in Caregivers of Melanoma and Sarcoma Patients: A Scoping Review. Cancers (Basel) Lleshi K, Shams M, Bergo E, Pluti M, Mocellin S, Del Fiore P, Feltrin A. PMID: 41827744 [PubMed]
	Adverse Events and Toxicity of Systemic Treatments for Uveal Melanoma: A Systematic Review. Cancers (Basel) Lanzafame K, Blanco G, Paratore S, Maratta MG, Russo A, Asero S, Ursino MG, Marino P, Bordonaro R. PMID: 41827715 [PubMed]
	Methods to include environmental impacts in a cost-effectiveness analysis: a case study of PET/CT surveillance imaging after treatment for stage III melanoma. Value Health Williams JTW, Bell KJL, McAlister S, Morton RL. PMID: 41825799 [PubMed - as supplied by publisher]
	Authors' reply regarding "Does tattoo exposure increase the risk of cutaneous melanoma: A population based case-control study". Eur J Epidemiol Rietz Liljedahl E, Nielsen K, Engfeldt M, Saxne Jöud A, Nielsen C. PMID: 41824157 [PubMed - as supplied by publisher]
	High frequency of mosaic NF2-related schwannomatosis diagnosed after somatic analysis of multi-nodular schwannomas in schwannomatosis patients. Hum Genet Peyre M, Barbance C, Tran S, Pacot L, Terris B, Kalamarides M, Parfait B. PMID: 41824074 [PubMed - indexed for MEDLINE]
	ACR Appropriateness CriteriaÂ® Staging and Follow-Up of Melanoma. J Am Coll Radiol Expert Panel on Systemic Oncology, Mejias C, Morgan RL, Arora SS, Carter BW, Chundury A, Corey AS, Kim L, Morin CE, Swami U, Terando A, Vorenkamp AE, Wolfman DJ, Wong TZ. PMID: 41823939 [PubMed - as supplied by publisher]
	A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTNÂ 9950). Cancer Bhatia A, Chen Z, Zhang Y, Bruce JY, Arnold S, Kaur V, Riess JW, Fenton M, Burtness B, Saba NF, Tara H, Steuer CE, Shin DM, Wasp G, Davis TH, Patel M, Schmitz JC, Bhateja P, Diavolitsis V, Zandberg DP, Mitchell DL, Kiesel BF, Kunos C, Gore SD, Carducci M, Beumer JH, Owonikoko TK. PMID: 41823504 [PubMed - indexed for MEDLINE]
	The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trial. Future Oncol Beard T, Guenther JM, Leong SP, Yamamoto M, Dierks S, Sickle-Santanello B, Ward A, Cripe M, Shah P, Young S. PMID: 41823171 [PubMed - as supplied by publisher]
	Associations of Social and Demographic Factors on the Outcomes of Ocular Melanoma and Other Adult Ocular Neoplasms in the United States: A Systematic Review. Cochrane Evid Synth Methods Shaughnessy D, Joshi V, Dellavalle N, Leslie L, Edwards M, Waxweiler T, Li T, Qureshi R. PMID: 41822909 [PubMed]

Articles 1 - 20 / 141936

Page 1 of 7097



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy